Use of this class of therapeutic agent requires cautious balancing of possible benefits against potential risks to the mother and foetus, especially in the first and third trimester. It should be avoided in patients who are breast-feeding.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
